Skip to main content
Premium Trial:

Request an Annual Quote

Vitra Introduces New Application for CellCard System

NEW YORK, Jan. 24 (GenomeWeb News) - Expanding its technologic product offering, Vitra Bioscience has made a nuclear translocation application available for its CellCard system for conducting highly multiplexed cell-based assays in high-content drug screening, the company said today.

 

According to the Mountain View, Calif.-based company, nuclear translocation is an important measure of cellular response to various drug therapies. Key proteins that undergo translocation are targets for anti-inflammatory drugs, while potential inhibitors of these proteins may have therapeutic benefits in treating cancer, Vitra said.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.